GLP-1 clinical trials enrolling now. Find one near you.
177 GLP-1 clinical trials covering 122 conditions are recruiting across 48 US states as of September 4, 2026. You pay nothing for the medication.
In every clinical trial here, the study medication and trial visits cost you nothing, and many pay you for your time. Some participants get a placebo, assigned at random.
Filters
- Who can join
- Adults 18+, have fatty liver disease (MASLD), BMI 25+.
- Where
- Alabama, Arizona and 33 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Children and teens 8 to 18, are overweight.
- Where
- California, Florida and 17 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have obesity, BMI 35+.
- Where
- Alabama, Arizona and 28 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have fatty liver disease (also called MASH or NASH) with liver scarring (fibrosis).
- Where
- Alabama, Arizona and 28 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have fatty liver disease (also called MASH or NASH), BMI 25+.
- Where
- Arizona, California and 23 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have type 2 diabetes, BMI 23+.
- Where
- Alabama, Arizona and 29 more states
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.Enrolling
- Who can join
- Children and teens 6 to 17, have obesity.
- Where
- Arizona, California and 27 more states
Study details
View on ClinicalTrials.gov → - A study testing whether a GLP-1 medicine from Lilly, orforglipron, can help people ease joint pain.Enrolling
- Who can join
- Adults 18+, have osteoarthritis (joint pain), BMI 27+.
- Where
- Arizona, California and 15 more states
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, have peripheral artery disease (poor blood flow in the legs), BMI 23+.
- Where
- Alabama, Arizona and 12 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, women only, have stress urinary incontinence (bladder leaks), BMI 27+.
- Where
- Alabama, Arizona and 9 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have obesity, BMI 35+.
- Where
- Arizona, Arkansas and 17 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have obesity or are overweight, BMI 25+.
- Where
- Alabama, Arizona and 16 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 70, have ulcerative colitis, BMI 27+.
- Where
- Alabama, California and 21 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 70, have Crohn's disease, BMI 27+.
- Where
- Alabama, California and 20 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18+, have type 2 diabetes, BMI 23+.
- Where
- Alabama, Arizona and 28 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have obesity, BMI 27+.
- Where
- Arizona, California and 20 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have type 2 diabetes.
- Where
- Alabama, California and 12 more states
Study details
View on ClinicalTrials.gov →- Who can join
- Adults 18 to 75, have type 2 diabetes, BMI 27+.
- Where
- Arizona, California and 12 more states
Study details
View on ClinicalTrials.gov →- A study testing whether a GLP-1 medicine from Lilly, orforglipron, can help people lose weight.Enrolling
- Who can join
- Children and teens 12 to 17, have obesity.
- Where
- California, Connecticut and 8 more states
Study details
View on ClinicalTrials.gov → - Who can join
- Adults 18+, have obesity, BMI 30+.
- Where
- Alabama, California and 15 more states
Study details
View on ClinicalTrials.gov →
How this directory works
The data comes from ClinicalTrials.gov, the US federal registry for clinical research. We pull active and pre-active GLP-1 clinical trials (semaglutide, tirzepatide, liraglutide, retatrutide, survodutide, orforglipron, cagrisema and related molecules) plus studies of GLP-1 effects on conditions like obesity, type 2 diabetes, MASH, sleep apnea, CKD, and cardiovascular disease.
Every Monday we check these listings against ClinicalTrials.gov. Before you contact a site, click through to its registry record and confirm the clinical trial is still recruiting. For the wider picture on getting a GLP-1 at no cost, see how to get a GLP-1 for free.
How to enroll in a clinical trial
- Find a clinical trial below or take the matching quiz. Read the eligibility criteria. The key inclusion and exclusion items are the ones the trial coordinator will check first.
- Find a site location near you. We list every US site with city, state, and contact information when the sponsor publishes it.
- Contact the site directly using the phone or email on the trial page. Tell them you read about the trial on GLP Chart and you want to be screened.
- Screening typically involves a phone call, a clinic visit, and sometimes blood work. Most clinical trials cover the cost of screening and trial-related medical care. Some sites compensate participants for their time; the trial coordinator explains what each site offers.
- If you do not qualify for the trial you contacted, ask the site coordinator about other clinical trials they run. Many sites run multiple GLP-1 studies at once and can route you to a better fit.
If a trial is not a fit and you need treatment now, the GLP-1 cost guide lays out what every legitimate cash-pay path costs at maintenance dose, starting at $149 a month for compounded semaglutide.
A few legal notes
GLP Chart is not affiliated with any of the sponsors or sites listed. We do not enroll patients in clinical trials, and we are not paid for clinical-trial referrals. If that changes, this page will say so on the day it does.
Participating in a clinical trial is a serious medical decision. Talk to your existing healthcare provider before enrolling. Trial coordinators are required by federal regulation to walk you through informed consent before you join.
GLP-1 clinical trials by state
1621 recruiting sites across 48 states. The number beside each state is how many studies are enrolling there.
- Alabama (16)
- Arizona (22)
- Arkansas (6)
- California (51)
- Colorado (18)
- Connecticut (12)
- Delaware (1)
- District of Columbia (1)
- Florida (41)
- Georgia (23)
- Hawaii (3)
- Idaho (11)
- Illinois (28)
- Indiana (18)
- Iowa (7)
- Kansas (12)
- Kentucky (14)
- Louisiana (16)
- Maine (1)
- Maryland (23)
- Massachusetts (19)
- Michigan (18)
- Minnesota (17)
- Mississippi (7)
- Missouri (21)
- Montana (4)
- Nebraska (5)
- Nevada (11)
- New Hampshire (3)
- New Jersey (12)
- New Mexico (4)
- New York (29)
- North Carolina (30)
- North Dakota (3)
- Ohio (28)
- Oklahoma (12)
- Oregon (4)
- Pennsylvania (32)
- Rhode Island (7)
- South Carolina (19)
- South Dakota (2)
- Tennessee (26)
- Texas (55)
- Utah (14)
- Virginia (25)
- Washington (26)
- West Virginia (4)
- Wisconsin (7)
Every clinical trial we track
All 226 GLP-1 clinical trials in this directory, including those that have not opened recruitment yet.
- Eli Lilly and Company metabolic dysfunction-associated steatotic liver disease clinical trial (NCT07165028)
- Novo Nordisk A/S overweight clinical trial (NCT07253285)
- Novo Nordisk A/S obesity clinical trial (NCT07564414)
- Boehringer Ingelheim metabolic dysfunction associated steatohepatitis (MASH) clinical trial (NCT06632444)
- Boehringer Ingelheim metabolic dysfunction associated steatohepatitis clinical trial (NCT06632457)
- Boehringer Ingelheim type 2 diabetes clinical trial (NCT07754461)
- Eli Lilly and Company obesity clinical trial (NCT06672549)
- Eli Lilly and Company overweight clinical trial (NCT07794579)
- Eli Lilly and Company osteoarthritis clinical trial (NCT07153471)
- Eli Lilly and Company peripheral arterial disease clinical trial (NCT07223593)
- Novo Nordisk A/S diabetes mellitus type 2 clinical trial (NCT07282613)
- Eli Lilly and Company urinary incontinence stress clinical trial (NCT07202884)
- Kailera obesity clinical trial (NCT07284979)
- Amgen obesity or overweight clinical trial (NCT07575399)
- Eli Lilly and Company ulcerative colitis clinical trial (NCT06937086)
- Eli Lilly and Company Crohn's disease clinical trial (NCT06937099)
- AstraZeneca type 2 diabetes mellitus clinical trial (NCT07662213)
- Eli Lilly and Company diabetes mellitus type 2 clinical trial (NCT07668336)
- Novo Nordisk A/S overweight clinical trial (NCT07668414)
- Eli Lilly and Company obesity clinical trial (NCT06143956)
- Novo Nordisk A/S diabetes mellitus type 2 clinical trial (NCT07668388)
- Eli Lilly and Company type 2 diabetes clinical trial (NCT06897475)
- Eli Lilly and Company obesity clinical trial (NCT06672939)
- Novo Nordisk A/S obesity clinical trial (NCT07639021)
- Eli Lilly and Company psoriatic arthritis clinical trial (NCT06864026)
- Eli Lilly and Company psoriasis clinical trial (NCT06857942)
- Novo Nordisk A/S diabetes mellitus type 2 clinical trial (NCT07415954)
- Altimmune, Inc. metabolic dysfunction-associated steatohepatitis (MASH) clinical trial (NCT07795164)
- Novo Nordisk A/S overweight clinical trial (NCT07770841)
- Eli Lilly and Company obesity clinical trial (NCT06439277)
- VA Office of Research and Development alcohol use disorder clinical trial (NCT07218354)
- Novo Nordisk A/S chronic kidney disease clinical trial (NCT06717698)
- Biomea Fusion Inc. type 2 diabetes clinical trial (NCT07502508)
- Novo Nordisk A/S overweight clinical trial (NCT07745504)
- Brigham and Women's Hospital type 2 diabetes clinical trial (NCT05390892)
- Vanda Pharmaceuticals nausea and vomiting clinical trial (NCT07446439)
- Novo Nordisk A/S obesity clinical trial (NCT07400107)
- Veru Inc. obesity & overweight clinical trial (NCT07446998)
- Antag Therapeutics adults with overweight/obesity and type 2 diabetes clinical trial (NCT07724340)
- Biomed Industries, Inc. obesity and overweight clinical trial (NCT06732245)
- Novo Nordisk A/S obesity clinical trial (NCT07607587)
- Regeneron Pharmaceuticals metabolic dysfunction-associated steatotic liver disease (MASLD) clinical trial (NCT07527910)
- Regeneron Pharmaceuticals overweight or obesity clinical trial (NCT07685808)
- Novo Nordisk A/S obesity clinical trial (NCT07184086)
- T. John Winhusen, PhD opioid use disorder clinical trial (NCT06651177)
- University of Florida endometrioid endometrial adenocarcinoma clinical trial (NCT07107334)
- The University of Texas Health Science Center at San Antonio type 2 diabetes (adult onset) clinical trial (NCT06246799)
- University of Colorado, Denver diabetes mellitus type 1 clinical trial (NCT05819138)
- University of Chicago overweight or obesity clinical trial (NCT06499857)
- Massachusetts General Hospital obesity clinical trial (NCT07729332)
- University of Colorado, Denver PCOS (polycystic ovary syndrome) of bilateral ovaries clinical trial (NCT05819853)
- Emory University diabetes mellitus type 2 clinical trial (NCT07428746)
- Children's Hospital Los Angeles pediatric obesity clinical trial (NCT06934655)
- University of Virginia obesity & overweight clinical trial (NCT07298915)
- University of Colorado, Denver obesity/therapy clinical trial (NCT07021937)
- AgelessRx longevity clinical trial (NCT07092618)
- Rutgers, The State University of New Jersey hormone receptor-positive breast cancer clinical trial (NCT06518837)
- Gila Therapeutics, Inc. obesity & overweight clinical trial (NCT07728383)
- Milton S. Hershey Medical Center opioid use disorder clinical trial (NCT06548490)
- University of Colorado, Denver menopause clinical trial (NCT06975111)
- Novo Nordisk A/S overweight clinical trial (NCT07767175)
- Novo Nordisk A/S obesity clinical trial (NCT07225816)
- University of Southern California smoking cessation clinical trial (NCT07602699)
- The Cleveland Clinic metabolic dysfunction-associated steatotic liver disease (MASLD) clinical trial (NCT06374875)
- Terrestrial Bio, Inc. overweight and/or obesity clinical trial (NCT07673900)
- Brigham and Women's Hospital alcohol use disorder (AUD) clinical trial (NCT06727331)
- Srinvasan Beddhu chronic kidney diseases clinical trial (NCT05173714)
- Shanghai World Leader Pharmaceutical Co., Ltd. overweight clinical trial (NCT07465965)
- The University of Texas Health Science Center, Houston obesity clinical trial (NCT06173778)
- Washington University School of Medicine lower back pain clinical trial (NCT07731256)
- AdventHealth Translational Research Institute diabetes mellitus type 1 clinical trial (NCT05478707)
- The University of Texas Health Science Center at San Antonio obesity prevention clinical trial (NCT06811324)
- University of Southern California alcohol use disorder clinical trial (NCT06994338)
- The Cleveland Clinic atrial fibrillation clinical trial (NCT06802081)
- Johns Hopkins University obesity and overweight clinical trial (NCT06847399)
- Yale University diabetes type 1 clinical trial (NCT06411210)
- University of Virginia obesity in children clinical trial (NCT06903923)
- St. Jude Children's Research Hospital acute lymphoblastic leukemia clinical trial (NCT07228741)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) metabolic alcohol-associated liver disease clinical trial (NCT07046819)
- Mayo Clinic type 1 diabetes clinical trial (NCT06976619)
- University of Washington diabetic kidney disease clinical trial (NCT05822609)
- University of Colorado, Denver autosomal dominant polycystic kidney clinical trial (NCT06582875)
- University of Alabama at Birmingham diabetes mellitus clinical trial (NCT04055428)
- Vanderbilt University Medical Center HIV clinical trial (NCT07221214)
- Grace Kim Prader-Willi syndrome clinical trial (NCT06901245)
- Massachusetts General Hospital obesity clinical trial (NCT05933499)
- Abbott Diabetes Care diabetes mellitus clinical trial (NCT06668935)
- Dan Zandberg melanoma clinical trial (NCT04114136)
- Washington University School of Medicine Crohn disease (CD) clinical trial (NCT06976853)
- Stanford University obesity clinical trial (NCT05912621)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) non-alcoholic steatohepatitis clinical trial (NCT03884075)
- University of Virginia NAFLD clinical trial (NCT05424003)
- Yale University alcohol use disorder (AUD) clinical trial (NCT07040592)
- University of Texas Southwestern Medical Center HFpEF - heart failure with preserved ejection fraction clinical trial (NCT07223242)
- Children's Hospital Medical Center, Cincinnati stage 1 diabetes mellitus type 1 clinical trial (NCT07430332)
- University of North Carolina, Chapel Hill pouch ileal clinical trial (NCT07756359)
- University of Massachusetts, Worcester gestational diabetes mellitus (GDM) clinical trial (NCT07797036)
- Vanderbilt University Medical Center type 2 diabetes mellitus (t 2 DM) clinical trial (NCT07760948)
- The Cleveland Clinic COPD clinical trial (NCT07747805)
- Johns Hopkins University alcohol use disorder clinical trial (NCT07249554)
- National Cancer Institute (NCI) endometrial atypical hyperplasia/endometrioid intraepithelial neoplasia clinical trial (NCT07349641)
- University of Pennsylvania cystic fibrosis clinical trial (NCT04731272)
- Pennington Biomedical Research Center musculoskeletal abnormalities clinical trial (NCT07154719)
- Marzieh Salehi spinal cord injuries clinical trial (NCT06706284)
- University of Maryland, Baltimore cocaine use disorder clinical trial (NCT06691243)
- Johns Hopkins University multiple sclerosis clinical trial (NCT07497399)
- Stanford University diabetes mellitus type 2 clinical trial (NCT06657209)
- Novo Nordisk A/S overweight clinical trial (NCT07627074)
- SIPPA Solutions INC type 2 diabetes clinical trial (NCT07032311)
- Johns Hopkins University central centrifugal cicatricial alopecia (CCCA) clinical trial (NCT07734870)
- Noom Inc. obesity & overweight clinical trial (NCT07588984)
- Alaa Sada mild autonomous cortisol secretion (MACS) clinical trial (NCT07573163)
- The Cleveland Clinic GLP - 1 clinical trial (NCT07127354)
- Mayo Clinic PreDiabetes clinical trial (NCT06967558)
- University of Missouri-Columbia morbid obesity clinical trial (NCT06132477)
- University of Virginia metabolic syndrome clinical trial (NCT04575844)
- Mayo Clinic bipolar i disorder clinical trial (NCT07213466)
- University of Michigan lipodystrophy partial clinical trial (NCT07091734)
- Columbia University heart failure diastolic clinical trial (NCT07554638)
- Massachusetts General Hospital genetic predisposition clinical trial (NCT06003153)
- Memorial Sloan Kettering Cancer Center endometrial cancer clinical trial (NCT06751589)
- Mansa maturity onset diabetes of the young clinical trial (NCT07029009)
- Baylor Research Institute breast cancer clinical trial (NCT06517212)
- University of Virginia heart failure preserved ejection fraction clinical trial (NCT07178145)
- Marlene Starr obesity and obesity-related medical conditions clinical trial (NCT06721507)
- The University of Texas Health Science Center, Houston cocaine use disorder clinical trial (NCT07227948)
- Weill Medical College of Cornell University obesity (disorder) clinical trial (NCT07257484)
- The University of Texas Medical Branch, Galveston aging clinical trial (NCT07220473)
- Mayo Clinic obesity clinical trial (NCT07218445)
- The Cleveland Clinic liver cirrhoses clinical trial (NCT07058155)
- Matthew J. Budoff type II diabetes clinical trial (NCT05708859)
- City of Hope Medical Center prostate carcinoma clinical trial (NCT07202247)
- University of Washington diabetes mellitus type 2 clinical trial (NCT05780905)
- San Francisco Department of Public Health methamphetamine-dependence clinical trial (NCT07204249)
- Brigham and Women's Hospital opioid use disorder clinical trial (NCT06639464)
- The University of Texas Health Science Center, Houston weight gain clinical trial (NCT07325500)
- Children's Hospital Medical Center, Cincinnati autism spectrum disorder clinical trial (NCT07770152)
- Baylor Research Institute chronic kidney disease clinical trial (NCT07547878)
- University of Minnesota obesity childhood clinical trial (NCT06977438)
- Goldman, Butterwick, Fitzpatrick and Groff laxity skin clinical trial (NCT07217743)
- Mayo Clinic genetic predisposition clinical trial (NCT06972407)
- William Marsh Rice University GLP - 1 clinical trial (NCT07554417)
- Ali Aminian atrial fibrillation clinical trial (NCT07027969)
- Stanford University prediabetes / type 2 diabetes clinical trial (NCT06682351)
- UNC Lineberger Comprehensive Cancer Center endometrial cancer clinical trial (NCT07078838)
- Goldman, Butterwick, Fitzpatrick and Groff wrinkle clinical trial (NCT07221461)
- Cytrellis Biosystems, Inc. glp 1 agonist clinical trial (NCT07224880)
- Athletic Greens International nutrition intake clinical trial (NCT07437911)
- Ocean Spray Cranberries, Inc. blood glucose clinical trial (NCT07103083)
- Ponsky Facial Aesthetics And Plastic Surgery, Llc facial skin aging clinical trial (NCT07760532)
- University of Miami Crohn disease clinical trial (NCT06774079)
- University of Virginia type 2 diabetes clinical trial (NCT03883412)
- Medical College of Wisconsin psoriatic arthritis (PsA) clinical trial (NCT07111494)
- The University of Texas Health Science Center, Houston PreDiabetes clinical trial (NCT05119179)
- Kalpna Kay Durairaj, MD, FACS volume loss (soft tissue ptosis or atrophy ) clinical trial (NCT07419854)
- Duke University idiopathic intracranial hypertension (IIH) clinical trial (NCT07191873)
- Columbia University healthy clinical trial (NCT05681299)
- Woman's pre diabetes clinical trial (NCT04873050)
- University of Oklahoma tobacco use clinical trial (NCT06986993)
- Mayo Clinic anatomic stage i breast cancer AJCC v 8 clinical trial (NCT07769047)
- National Institute on Alcohol Abuse and Alcoholism (NIAAA) alcohol use disorder (AUD) clinical trial (NCT07559500)
- University of Maryland, Baltimore obesity clinical trial (NCT05071898)
- The Methodist Hospital Research Institute alzheimer dementia (AD) clinical trial (NCT07651319)
- University of Colorado, Denver obesity clinical trial (NCT06575738)
- The University of Texas Health Science Center at San Antonio pre-diabetes clinical trial (NCT06446531)
- Yale University alcohol use disorder clinical trial (NCT07223983)
- University of Pennsylvania obesity clinical trial (NCT05746039)
- Yale University alcohol use disorder (AUD) clinical trial (NCT07772960)
- Dr. Christopher McGowan obesity and obesity-related medical conditions clinical trial (NCT06734312)
- UNC Lineberger Comprehensive Cancer Center endometrial cancer clinical trial (NCT07065552)
- Nicholas Skertich obesity and obesity-related medical conditions clinical trial (NCT06734273)
- University of Texas at Austin obesity clinical trial (NCT07480109)
- University of New Mexico MASLD clinical trial (NCT06934642)
- Nemours Children's Clinic polycystic ovarian syndrome in adolescent females clinical trial (NCT07169136)
- Brigham and Women's Hospital overweight and obesity clinical trial (NCT06069622)
- University of Pennsylvania diabetic nephropathies clinical trial (NCT07444203)
- Penn State University weight loss clinical trial (NCT06843512)
- Washington University School of Medicine obesity clinical trial (NCT07091500)
- Advanced Reconstructive Surgery Alliance lymphedema clinical trial (NCT07012642)
- Massachusetts General Hospital obesity clinical trial (NCT07226947)
- Ian J. Neeland, MD dietary change clinical trial (NCT07244458)
- University of Colorado, Denver lactation clinical trial (NCT07720414)
- University of California, Los Angeles obesity clinical trial (NCT05419726)
- The University of Texas Health Science Center at San Antonio post bariatric surgery clinical trial (NCT02823665)
- The University of Texas Health Science Center at San Antonio post-bariatric surgery clinical trial (NCT01803451)
- Texas Tech University obesity & overweight clinical trial (NCT07740291)
- Ohio State University obesity & overweight clinical trial (NCT07702461)
- David D'Alessio, M.D. diabetes (DM) clinical trial (NCT07224334)
- University of Pittsburgh muscle composition clinical trial (NCT07652333)
- Massachusetts General Hospital colorectal cancer prevention clinical trial (NCT07095517)
- University of Kansas Medical Center pregnant individuals clinical trial (NCT07743567)
- State University of New York at Buffalo obesity & overweight clinical trial (NCT07641361)
- Ian J. Neeland, MD dietary change clinical trial (NCT07244445)
- The University of Texas Health Science Center at San Antonio post bariatricsurgery clinical trial (NCT00992901)
- John Bauer obesity and overweight clinical trial (NCT06967389)
- University of Chicago lung cancer clinical trial (NCT07782359)
- Louisiana State University and A&M College women's health clinical trial (NCT07787533)
- Hartford HealthCare lower urinary tract symptoms clinical trial (NCT07175805)
- University of Alabama at Birmingham weight loss clinical trial (NCT07535892)
- Vanderbilt University Medical Center duchenne muscular dystrophy (DMD) clinical trial (NCT07642635)
- Pennington Biomedical Research Center obesity clinical trial (NCT07796204)
- University of Wisconsin, Madison GLP-1 clinical trial (NCT07758231)
- Oelisoa Andriankaja obesity clinical trial (NCT07478653)
- The Cleveland Clinic type 2 diabetes clinical trial (NCT07695454)
- M.D. Anderson Cancer Center diabetes clinical trial (NCT06759701)
- Vanderbilt University Medical Center type 1 diabetes clinical trial (NCT06338553)
- Benjamin T. Miller abdominal wall hernia clinical trial (NCT05925959)
- University of Arizona pancreatic cancer clinical trial (NCT07627191)
- Banner Health prostate cancer clinical trial (NCT07727473)
- The University of Texas at Dallas drug discontinuation clinical trial (NCT07387796)
- University of Pennsylvania cystic fibrosis clinical trial (NCT01851694)
- Duk-Woo Park, MD coronary artery stenosis clinical trial (NCT05831085)
- Mayo Clinic upper endoscopy clinical trial (NCT07006142)
- Nanjing Nutrabuilding Bio-tech Co., Ltd. prediabetes clinical trial (NCT07210684)
- Medical University of South Carolina gastric retention clinical trial (NCT07251803)
- The University of Texas Health Science Center, Houston pulmonary aspiration clinical trial (NCT06654219)
- Purdue University blood glucose clinical trial (NCT07572513)
- Saundra Jain wellness clinical trial (NCT07760896)
- University of Massachusetts, Worcester GLP - 1 clinical trial (NCT07481305)
- University of Texas Southwestern Medical Center mild autonomous cortisol secretion (MACS) clinical trial (NCT07361874)
- Northwestern University multiple sclerosis clinical trial (NCT07207148)
- Virginia Polytechnic Institute and State University muscle mass clinical trial (NCT07104539)
- University of Arkansas pre-op gastric emptying clinical trial (NCT06814080)
- Goldman, Butterwick, Fitzpatrick and Groff laxity skin clinical trial (NCT07558603)
- The Cleveland Clinic diabetes clinical trial (NCT07784127)
- Tufts University weight maintenance clinical trial (NCT07701460)